Revolutionizing Kidney Cancer Therapy: The Transformative Role of Nanomedicines and Drug Conjugates

Authors: Radhakrishnan HR*

DOI: 10.23880/nnoa-16000327

Volume 9, Issue 4

Abstract

The emergence of nanotechnology-based Nano-drug conjugates in cancer therapy, notably for kidney cancer, marks a paradigm change in how we approach treatment. Kidney cancer, notably renal cell carcinoma (RCC), has historically presented substantial problems due to the difficulty of targeting malignant cells while preserving healthy organs. Traditional interventions, such as surgery, radiation, and chemotherapy, can produce non-specific toxicity and unwanted side effects. Nano drug conjugates provide a fresh, more precise route for drug delivery, greatly increasing therapy effectiveness while reducing systemic toxicity.

Keywords: Drug Conjugates; Nanomedicine; Cancer Therapy

View PDF